- Home
- LSEA vs ENGN Comparison
LSEA vs ENGN Comparison
Compare LSEA & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSEA
- ENGN
- Stock Information
- Founded
- LSEA 2013
- ENGN 1999
- Country
- LSEA United States
- ENGN Canada
- Employees
- LSEA N/A
- ENGN N/A
- Industry
- LSEA Homebuilding
- ENGN
- Sector
- LSEA Consumer Discretionary
- ENGN
- Exchange
- LSEA Nasdaq
- ENGN Nasdaq
- Market Cap
- LSEA 222.1M
- ENGN 297.7M
- IPO Year
- LSEA N/A
- ENGN N/A
- Fundamental
- Price
- LSEA $6.10
- ENGN $3.39
- Analyst Decision
- LSEA Buy
- ENGN Buy
- Analyst Count
- LSEA 4
- ENGN 7
- Target Price
- LSEA $13.50
- ENGN $23.29
- AVG Volume (30 Days)
- LSEA 200.4K
- ENGN 54.9K
- Earning Date
- LSEA 05-12-2025
- ENGN 06-13-2025
- Dividend Yield
- LSEA N/A
- ENGN N/A
- EPS Growth
- LSEA N/A
- ENGN N/A
- EPS
- LSEA 0.47
- ENGN N/A
- Revenue
- LSEA $1,550,337,000.00
- ENGN N/A
- Revenue This Year
- LSEA N/A
- ENGN N/A
- Revenue Next Year
- LSEA $3.52
- ENGN N/A
- P/E Ratio
- LSEA $12.98
- ENGN N/A
- Revenue Growth
- LSEA 28.13
- ENGN N/A
- 52 Week Low
- LSEA $5.41
- ENGN $3.27
- 52 Week High
- LSEA $14.04
- ENGN $14.67
- Technical
- Relative Strength Index (RSI)
- LSEA 48.21
- ENGN 27.30
- Support Level
- LSEA $5.79
- ENGN $3.51
- Resistance Level
- LSEA $6.25
- ENGN $3.99
- Average True Range (ATR)
- LSEA 0.31
- ENGN 0.40
- MACD
- LSEA 0.04
- ENGN -0.00
- Stochastic Oscillator
- LSEA 43.02
- ENGN 10.71
About LSEA Landsea Homes Corporation
Landsea Homes Corp is a growth-oriented homebuilder focused on providing High-Performance Homes that deliver energy-efficient living in attractive geographies. It is engaged in the design, construction, marketing and sale of suburban and urban single-family detached and attached homes in Arizona, California, Colorado, Florida, Texas, and Metro New York. While It offers a wide range of housing options, it focuses on entry-level and first-time move-up homes and believes its markets are characterized by attractive long-term housing fundamentals. The company's segments include Arizona, California, Colorado, Florida, Metro New York, and Texas. It derives a majority of its revenue from home sales in Florida.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.